These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21183209)

  • 1. Aprotinin, but not tranexamic acid, is associated with increased pulmonary microvascular fibrin deposition after cardiac surgery.
    Dixon B; Nixon I; Kenny J; Newcomb AE; Rosalion A; Opeskin K; Stamaratis G; Silbert BS; Said S; Santamaria JD; Campbell DJ
    Thromb Res; 2011 Mar; 127(3):272-4. PubMed ID: 21183209
    [No Abstract]   [Full Text] [Related]  

  • 2. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
    Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.
    Martin K; Wiesner G; Breuer T; Lange R; Tassani P
    Anesth Analg; 2008 Dec; 107(6):1783-90. PubMed ID: 19020118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk-benefit profile of aprotinin versus tranexamic acid in cardiac surgery.
    Karkouti K; Wijeysundera DN; Yau TM; McCluskey SA; Tait G; Beattie WS
    Anesth Analg; 2010 Jan; 110(1):21-9. PubMed ID: 19910626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. eComment: A comparison of the safety of aprotinin and tranexamic acid in cardiac surgery.
    Koniari I; Apostolakis E; Mandellou M
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):101. PubMed ID: 19546299
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality manifesto: a meta-analysis of aprotinin and tranexamic acid mortality.
    Brown JR
    Eur J Cardiothorac Surg; 2009 Oct; 36(4):781-2. PubMed ID: 19616962
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
    Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
    N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
    Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aprotinin increases mortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials.
    Takagi H; Manabe H; Kawai N; Goto SN; Umemoto T
    Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):98-101. PubMed ID: 19380335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
    Ngaage DL; Bland JM
    Eur J Cardiothorac Surg; 2010 Jun; 37(6):1375-83. PubMed ID: 20117944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk associated with aprotinin in cardiac surgery.
    Mangano DT; Tudor IC; Dietzel C; ;
    N Engl J Med; 2006 Jan; 354(4):353-65. PubMed ID: 16436767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
    Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
    Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and efficacy of tranexamic acid compared with aprotinin in thoracic aortic surgery with deep hypothermic circulatory arrest.
    Nicolau-Raducu R; Subramaniam K; Marquez J; Wells C; Hilmi I; Sullivan E
    J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):73-9. PubMed ID: 19717314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.
    Chauhan S
    Ann Card Anaesth; 2015; 18(1):27-8. PubMed ID: 25566707
    [No Abstract]   [Full Text] [Related]  

  • 15. Convulsive seizures following subdural application of fibrin sealant containing tranexamic acid in a rat model.
    Schlag MG; Hopf R; Redl H
    Neurosurgery; 2000 Dec; 47(6):1463-7. PubMed ID: 11126922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tranexamic Acid in cardiac surgery and postoperative seizures: a case report series.
    Bell D; Marasco S; Almeida A; Rowland M
    Heart Surg Forum; 2010 Aug; 13(4):E257-9. PubMed ID: 20719731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of aprotinin and tranexamic acid in pulmonary endarterectomy surgery with hypothermia: review of 200 patients.
    Berman M; Cardone D; Sharples L; Vuylsteke A; Klein A; Gerrard C; Dunning J; Tsui S; Jenkins D
    Ann Thorac Surg; 2010 Nov; 90(5):1432-6. PubMed ID: 20971234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic therapy in complex spine surgery: a case-control study comparing aprotinin and tranexamic acid.
    Colomina MJ; Bagó J; Vidal X; Mora L; Pellisé F
    Orthopedics; 2009 Feb; 32(2):91. PubMed ID: 19301800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A propensity score case-control comparison of aprotinin and tranexamic acid in high-transfusion-risk cardiac surgery.
    Karkouti K; Beattie WS; Dattilo KM; McCluskey SA; Ghannam M; Hamdy A; Wijeysundera DN; Fedorko L; Yau TM
    Transfusion; 2006 Mar; 46(3):327-38. PubMed ID: 16533273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.